These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26739079)

  • 21. [Diagnostic Value of Combining Permeability with T1 Perfusion Parameters in Quantitative Dynamic Contrast-enhanced Magnetic Resonance Imaging for Glioma Grading].
    Sun SJ; Qian HF; Li FQ; Li ZY; Wu X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2015 Dec; 37(6):674-80. PubMed ID: 26725390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
    Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility and value of quantitative dynamic contrast enhancement MR imaging in the evaluation of sinonasal tumors.
    Xian J; Du H; Wang X; Yan F; Zhang Z; Hao H; Zhao B; Tong Y; Zhang J; Han D
    Chin Med J (Engl); 2014; 127(12):2259-64. PubMed ID: 24931238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic approach for dynamic breast MRI to indicate signal intensity time curves of benign and malignant lesions by using the tumor flow residence time.
    Renz DM; Diekmann F; Schmitzberger FF; Pietsch H; Fallenberg EM; Durmus T; Huppertz A; Böttcher J; Bick U; Hamm B; Lawaczeck R
    Invest Radiol; 2013 Feb; 48(2):69-78. PubMed ID: 23262793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic contrast-enhanced magnetic resonance perfusion volumetrics can differentiate tuberculosis of the spine and vertebral malignancy.
    Verma M; Sood S; Singh B; Thakur M; Sharma S
    Acta Radiol; 2022 Nov; 63(11):1504-1512. PubMed ID: 34806421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of dynamic contrast-enhanced magnetic resonance imaging in the differentiation of pancreatic ductal adenocarcinoma from other pancreatic solid lesions.
    Liu K; Xie P; Peng W; Zhou Z
    J Comput Assist Tomogr; 2014; 38(5):681-6. PubMed ID: 24943251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The actions of diffusion weighted imaging (DWI) and dynamic contrast enhanced MRI in differentiating breast tumors].
    Luo Y; Yu J; Chen D; Xu Z; Zeng H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2013 Dec; 30(6):1219-23. PubMed ID: 24645600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of dynamic contrast-enhanced magnetic resonance imaging for differentiating glioblastoma, primary central nervous system lymphoma and brain metastatic tumor.
    Lu S; Gao Q; Yu J; Li Y; Cao P; Shi H; Hong X
    Eur J Radiol; 2016 Oct; 85(10):1722-1727. PubMed ID: 27666608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic value of combined diffusion-weighted imaging with dynamic contrast enhancement MRI in differentiating malignant from benign bone lesions.
    Cao J; Xiao L; He B; Zhang G; Dong J; Wu Y; Xie H; Wang G; Lin X
    Clin Radiol; 2017 Sep; 72(9):793.e1-793.e9. PubMed ID: 28545685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Preliminary study of semi-quantitative and quantitative dynamic contrast-enhanced MRI in evaluating the response to concurrent chemoradiotherapy in patients with non-small cell lung cancer].
    Xiuli T; Han O; Ning W; Li L; Feng Y; Ying S; Peihua W; Lü L
    Zhonghua Zhong Liu Za Zhi; 2015 Apr; 37(4):272-7. PubMed ID: 26462891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China.
    Fan WX; Chen XF; Cheng FY; Cheng YB; Xu T; Zhu WB; Zhu XL; Li GJ; Li S
    Medicine (Baltimore); 2018 Jan; 97(4):e9666. PubMed ID: 29369183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-palpable incidentally found testicular tumors: Differentiation between benign, malignant, and burned-out tumors using dynamic contrast-enhanced MRI.
    El Sanharawi I; Correas JM; Glas L; Ferlicot S; Izard V; Ducot B; Bellin MF; Benoît G; Rocher L
    Eur J Radiol; 2016 Nov; 85(11):2072-2082. PubMed ID: 27776661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiparametric approach with diffusion-weighted imaging and dynamic contrast-enhanced MRI: a comparison study for differentiating between benign and malignant bone lesions in adults.
    Oh E; Yoon YC; Kim JH; Kim K
    Clin Radiol; 2017 Jul; 72(7):552-559. PubMed ID: 28325514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The application of dynamic contrast-enhanced MRI and diffusion-weighted MRI in patients with maxillofacial tumors.
    Kitamoto E; Chikui T; Kawano S; Ohga M; Kobayashi K; Matsuo Y; Yoshiura T; Obara M; Honda H; Yoshiura K
    Acad Radiol; 2015 Feb; 22(2):210-6. PubMed ID: 25442795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic Contrast-Enhanced MR Perfusion in Differentiation of Benign and Malignant Brain Lesions.
    Cetinkaya E; Aralasmak A; Atasoy B; Tokdemir S; Toprak H; Toprak A; Kurtcan S; Alkan A
    Curr Med Imaging; 2022; 18(10):1099-1105. PubMed ID: 35331119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating the Microcirculation of Normal Extraocular Muscles Using Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
    Guo Y; Huo L; Wang P; Huang L; Chai C; Sun F; Xia S; Shen W
    J Comput Assist Tomogr; 2016; 40(3):419-23. PubMed ID: 26953768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative dynamic contrast-enhanced and diffusion-weighted MRI for differentiation between nasopharyngeal carcinoma and lymphoma at the primary site.
    Yu XP; Hou J; Li FP; Xiang W; Lu Q; Hu Y; Wang H
    Dentomaxillofac Radiol; 2016; 45(3):20150317. PubMed ID: 26846711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiation of malignant from benign pheochromocytomas with diffusion-weighted and dynamic contrast-enhanced magnetic resonance at 3.0 T.
    Dong Y; Liu Q
    J Comput Assist Tomogr; 2012; 36(4):361-6. PubMed ID: 22805661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
    Ocak I; Bernardo M; Metzger G; Barrett T; Pinto P; Albert PS; Choyke PL
    AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of dynamic contrast-enhanced MRI in characterizing complex ovarian tumors.
    Li HM; Qiang JW; Ma FH; Zhao SH
    J Ovarian Res; 2017 Jan; 10(1):4. PubMed ID: 28088245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.